Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation

Nephrology Dialysis Transplantation

Volumn 20, Issue SUPPL. 2, 2005, Pages

  Berney, Thierry ^a   Malaise, Jacques ^b   Morel, Philippe ^a   Toso, Christian ^a   Demuylder Mischler, Sandrine ^a   Majno, Pietro ^a   Bühler, Léo H ^a   Mentha, Gilles ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Graft survival; HLA matching; Kidney pancreas transplantation; Multicentre study; Prospective study; Rejection

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DONOR; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; GRAFT SURVIVAL; HLA TYPING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; PANCREAS FUNCTION TEST; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; AGE FACTORS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; EUROPE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISRAEL; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; PROSPECTIVE STUDIES; TISSUE DONORS;

EID: 18844376336     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh1082     Document Type: Article

References (27)

1. Kaufman DB. Pancreas transplantation. In: Stuart FP, Abecassis MM, Kaufman DB, eds. Organ Transplantation. Landes Bioscience, Texas; 2000: 145-168
2. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002. In: Cecka JM, Terasaki PI, eds. Clin Transplant. UCLA Immunogenetics Center, Los Angeles, CA; 2002: 41-77
3. Troppmann C, Gruessner AC, Benedetti E et al. Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg 1996; 182: 285-316
4. Gruessner RWG, Sutherland DER. Pancreas transplantation II: the recipient operation. Surg Rounds 1994; 17: 383-391
5. Gruessner RW, Troppmann C, Barrou B et al. Assessment of donor and recipient risk factors on pancreas transplant outcome. Transplant Proc 1994; 26: 437-438
6. Opelz G, Wujciak T, Dohler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet 1999; 1: 334-342
7. Cecka JM. The UNOS renal transplant registry. In: Cecka JM, Terasaki PI, eds. Clin Transplant. UCLA Immunogenetics Center, Los Angeles, CA; 2002: 1-20
8. Mitsuishi Y, Cecka JM. Disease effects and associations. In: Cecka JM, Terasaki PI, eds. Clin Transplant. UCLA Immunogenetics Center, Los Angeles, CA; 1992: 371-381
9. Bechstein WO, Malaise J, Saudek F et al. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. Transplantation 2004; 77: 1221-1228
10. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612
11. Mancini MJ, Connors AF Jr, Wang XQ et al. HLA matching for simultaneous pancreas-kidney transplantation in the United States: a multivariable analysis of the UNOS data. Clin Nephrol 2002; 57: 27-37
12. Sutherland DE, Gruessner RW, Dunn DL et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233: 463-501
13. Odorico JS, Sollinger HW. Technical and immunosuppressive advances in transplantation for insulin-dependent diabetes mellitus. World J Surg 2002; 26: 194-211
14. Squifflet JP, Moudry K, Sutherland DE. Is HLA matching relevant in pancreas transplantation? A registry analysis. Transplant Int 1988; 1: 26-29
15. So SK, Minford EJ, Moudry-Munns KC, Gillingham K, Sutherland DE. DR matching improves cadaveric pancreas transplant results. Transplant Proc 1990; 22: 687-688
16. Gores PF, Gillingham KJ, Dunn DL, Moudry-Munns KC, Najarian JS, Sutherland DE. Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in a multivariate analysis of a single institution's experience. Ann Surg 1992; 215: 217-230
17. Sasaki T, Pirsch JD, Ploeg RJ et al. Effects of DR mismatch on long-term graft survival in simultaneous kidney-pancreas transplantation. Transplant Proc 1993; 25: 237-238
18. Hartgrink HH, van Bockel JH, Hansen B et al. Effect of blood group and HLA matching on pancreas graft survival with the use of UW solution. Transplant Int 1995; 8: 366-373
19. Gruessner AC, Sutherland DER, Gruessner RWG. Matching in pancreas transplantation - a registry analysis. Transplant Proc 2001; 33: 1665-1666
20. http://www.optn.org. Organ Procurement and Transplantation Network official website. Accessed February 2004
21. Cohen B, Persijn GG. Eurotransplant International Foundation Annual Report, CIP-Gegrevens Koninklijke Bibliotheek, Den Haag, The Netherlands; 2002: 43-48
22. Gruessner AC, Sutherland DER, Gruessner RWG. The impact of CREG matching on pancreas (PA) transplant (TX) outcome: a registry analysis. Am J Transplant 2002; 2 [Suppl 3]: 170 [Abstract 130]
23. Thompson JS, Thacker LR. CREG matching for first cadaveric kidney transplants (TNX) performed by SEOPF centers between October 1987 and September 1995. Southeastern Organ Procurement Foundation. Clin Transplant 1996; 10: 586-593
24. Crowe DO. The effect of cross-reactive epitope group matching on allocation and sensitization. Clin Transplant 2003; 17 [Suppl 9]: 13-16
25. Stobbe I, van der Meer-Prins EM, de Lange P et al. Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys. Transplantation 2000; 70: 157-161
26. Markmann JF, Posselt AM, Bassiri H et al. Major-histocompatibility-complex restricted and nonrestricted autoimmune effector mechanisms in BB rats. Transplantation 1991; 52: 662-667
27. Makhlouf L, Kishimoto K, Smith RN et al. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Diabetes 2002; 51: 3202-3210